enow.com Web Search

  1. Ads

    related to: new asthma treatment guidelines

Search results

  1. Results from the WOW.Com Content Network
  2. Doctors urged to ditch blue inhalers for asthma treatment ...

    www.aol.com/news/doctors-urged-ditch-blue...

    In a “true pivot” in asthma care across the UK, new guidelines urge medics to offer inhalers that both relieve and prevent symptoms to newly diagnosed sufferers who are 12 and over, rather ...

  3. Indacaterol/glycopyrronium bromide/mometasone - Wikipedia

    en.wikipedia.org/wiki/Indacaterol/glycopyrronium...

    It is the first asthma triple-combination therapy; it consists of a fixed-dose combination of three active substances (indacaterol, glycopyrronium bromide and mometasone furoate) in capsules, to be administered using an inhaler. [11] An optional electronic sensor may also be co-packed with the product. [11]

  4. If You're Living With Asthma, Here's Every Single Treatment ...

    www.aol.com/youre-living-asthma-heres-every...

    Treat an asthma attack by visiting the hospital. Every year, more than 1.6 million Americans wind up in the emergency room because of an asthma attack, according to the CDC.If your attack is so ...

  5. Anti-asthmatic agent - Wikipedia

    en.wikipedia.org/wiki/Anti-asthmatic_agent

    According to the Global Initiative of Asthma (GINA), the guideline for anti-asthmatic treatment is divided into 5 levels according to asthma severity. [31] For newly diagnosed asthma patients, the 5 levels derived from the severity of asthma depend on the occurrence of symptoms and their frequencies.

  6. Dexpramipexole - Wikipedia

    en.wikipedia.org/wiki/Dexpramipexole

    Dexpramipexole is a first-in-class oral investigational medicine that lowers blood and tissue eosinophils before they can cause damage in the target organ. Dexpramipexole is being developed by Areteia Therapeutics and has the potential to be the first oral treatment ever approved for eosinophilic asthma.

  7. First Advanced Oral Treatment For Asthma - Sanofi's ... - AOL

    www.aol.com/first-advanced-oral-treatment-asthma...

    Wednesday, Sanofi SA (NASDAQ:SNY) reported results from the Phase 2 study of oral rilzabrutinib in adult patients with uncontrolled moderate-to-severe asthma. Two doses of rilzabrutinib, 800 mg ...

  1. Ads

    related to: new asthma treatment guidelines